v3.26.1
Stock-Based Compensation
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

8. Stock-Based Compensation

The Company’s Fourth Amended and Restated 2006 Stock Option and Incentive Plan allows for granting of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock units, performance-based restricted stock units, unrestricted stock awards, and deferred stock awards to its officers, employees, directors, and consultants. The components of stock-based compensation expense included in the consolidated statements of operations are as follows:

 

 

Three months ended

 

 

Six months ended

 

 

June 30,

 

 

June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(in thousands)

 

 

(in thousands)

 

Stock option awards

 

$

813

 

 

$

910

 

 

$

1,677

 

 

$

1,810

 

Restricted stock units

 

 

688

 

 

 

634

 

 

 

1,357

 

 

 

1,320

 

Performance-based restricted stock units

 

 

434

 

 

 

400

 

 

 

993

 

 

 

860

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock-based compensation

 

$

1,935

 

 

$

1,944

 

 

$

4,027

 

 

$

3,990

 

 

 

Stock-based compensation is included in the Company’s consolidated statements of operations as follows:

 

 

Three months ended

 

 

Six months ended

 

 

June 30,

 

 

June 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(in thousands)

 

 

(in thousands)

 

Cost of sales

 

$

320

 

 

$

266

 

 

$

609

 

 

$

552

 

Sales and marketing

 

 

304

 

 

 

349

 

 

 

611

 

 

 

725

 

General and administrative

 

 

1,140

 

 

 

1,140

 

 

 

2,412

 

 

 

2,316

 

Research and development

 

 

171

 

 

 

189

 

 

 

395

 

 

 

397

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total stock-based compensation

 

$

1,935

 

 

$

1,944

 

 

$

4,027

 

 

$

3,990

 

 

During the six months ended June 30, 2026, the Company granted 520 restricted stock units. The Company did not grant any options or performance-based restricted stock units during the six months ended June 30, 2026. During the six months ended June 30, 2025, the Company granted 741 options, 1,521 restricted stock units, and 129 performance-based restricted stock units. The Company issued 97,298 and 93,658 shares of common stock following the exercise or vesting of underlying stock options, restricted stock units, and performance-based restricted stock units during the six months ended June 30, 2026 and 2025, respectively.